About this content Oliver has been writing about companies and markets since the early 2000s, cutting his teeth as a financial journalist at Growth Company Investor with a focusing on AIM companies and small caps, before a few years later becoming a section editor and then head of research. He joined Proactive after a couple of years freelancing, where he worked for the Financial Times Group, ITV, Press Association, Reuters sports desk, the London Olympic News Service, Rugby World Cup News Service, Gracenot ...

Spectral AI's DeepView™ System is a predictive device that offers clinicians an immediate and objective assessment of a burn wound's healing potential prior to treatment or other medical intervention. The image processing algorithm employed by the DeepView™ System utilizes multispectral imaging that is trained and tested against a proprietary database of more than 340 billion clinically validated data points. The DeepView™ System is non-invasive and cart-based, allowing for exceptional mobility within the h ...

About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government. S ...

DALLAS, July 02, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it has achieved 100% pediatric patient enrollment at burn centers for its 2024 pivotal study designed to validate the AI-driven algorithm used by its DeepView™ System for its burn indication. "Due to the investigators' enthusiasm and the potential ...

Core Insights - Spectral AI has achieved 100% pediatric patient enrollment at burn centers for its pivotal study on the DeepView™ System, which is designed to validate an AI-driven algorithm for burn treatment [1][2][3] - The pivotal study is expected to be completed in Q4 2024, leading to a potential FDA approval for the DeepView™ System in 2025 [2] - The DeepView™ System utilizes proprietary multispectral imaging and has been trained against a database of over 340 billion clinically validated data points to assess burn wounds accurately [3][4] Company Overview - Spectral AI, Inc. is focused on medical diagnostics, particularly in wound care, with applications for burns and diabetic foot ulcers [4] - The DeepView System aims to provide objective and immediate assessments of wound healing potential, thereby improving patient outcomes and reducing healthcare costs [4]

DALLAS, July 01, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced its inclusion in the Russell Microcap Index following the annual Russell Reconstitution, which took effect after the market close on June 28, 2024. The reconstituted Russell Microcap Index will commence trading on July 1, 2024. Mr. Carlson highlighted ...

DALLAS, July 01, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced its inclusion in the Russell Microcap Index following the annual Russell Reconstitution, which took effect after the market close on June 28, 2024. The reconstituted Russell Microcap Index will commence trading on July 1, 2024. In June, the Company ach ...

Group 1 - Proactive provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [4] - The company focuses on medium and small-cap markets while also covering blue-chip companies, commodities, and broader investment stories [2] - Proactive's news team spans key finance and investing hubs globally, including London, New York, Toronto, Vancouver, Sydney, and Perth [1] Group 2 - The content delivered by Proactive includes insights across various sectors such as biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto, and emerging digital and EV technologies [5] - Proactive employs technology to enhance workflows, utilizing automation and software tools, including generative AI, while ensuring all content is edited and authored by humans [6] - The company has a strong journalism background, with its team members having experience in reporting on business, legal, and scientific developments [1]

DALLAS, June 27, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it has surpassed 90% of the enrollment target for pediatric patients at burn centers for its 2024 pivotal study designed to validate the AI-driven algorithm used by its DeepView™ System for its burn indication. "We are excited with the progress on ...

About Emily Jarvie Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is produced independently by our experienced and qualified teams of news journalists. Use of technology About this content About the publisher We are experts in medium and small-cap markets, we also keep our community up to date with blue-chip companies, commodities and broader investment stories. This i ...